发明名称 METHOD OF MEASURING HUMAN CYP3A INDUCIBILITY
摘要 A method for measuring human CYP3A inducibility upon administration of a test drug, characterized in that a non-human animal to which a test drug is administered or a population of human cells cultured in a medium containing a test drug is infected with viruses (A) and (B); virus (A) being an adenovirus which is used as a vector and engineered by incorporating thereto a detectable reporter gene an;d at least 3 human PXR binding regions falling within an untranslated region of a human CYP3A gene, and virus (B) being an adenovirus which is used as a vector and engineered by incorporating thereto a human PXR cDNA; and subsequently expression level of the reporter gene is determined in the non-human animal or the cultured human cells. The present invention ensures convenient and accurate evaluation of human CYP3A inducibility upon administration of a test drug to a human subject, providing accurate evaluation in terms of the efficacy of the test drug, occurrence of side effects, disappearance of the drug effect, etc.
申请公布号 US2014127706(A1) 申请公布日期 2014.05.08
申请号 US201314136638 申请日期 2013.12.20
申请人 SEKISUI MEDICAL CO., LTD. 发明人 YAMAZOE YASUSHI;NAGATA KIYOSHI
分类号 C12N15/09;C12Q1/68;C12N5/10;C12N7/00;C12Q1/02;C12Q1/26;C12Q1/66;C12Q1/70;G01N33/50 主分类号 C12N15/09
代理机构 代理人
主权项
地址